Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2014, Article ID 701094, 12 pages
http://dx.doi.org/10.1155/2014/701094
Research Article

Overexpression and Selectively Regulatory Roles of IL-23/IL-17 Axis in the Lesions of Oral Lichen Planus

1State Key Laboratory of Oral Diseases, West China College of Stomatology, Sichuan University, No. 14, Section 3, Renminnan Road, Chengdu 610041, China
2The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) and Key Laboratory of Oral Biomedicine Ministry of Education, School and Hospital of Stomatology, Wuhan University, No. 237 Luoyu Road, Wuhan 430079, China

Received 3 November 2013; Revised 14 May 2014; Accepted 28 May 2014; Published 8 July 2014

Academic Editor: Gilles Chiocchia

Copyright © 2014 Rui Lu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Lodi, C. Scully, M. Carrozzo, M. Griffiths, P. B. Sugerman, and K. Thongprasom, “Current controversies in oral lichen planus: report of an international consensus meeting. Part 1. Viral infections and etiopathogenesis,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology, vol. 100, no. 1, pp. 40–51, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. P. B. Sugerman, N. W. Savage, L. J. Walsh et al., “The pathogenesis of oral lichen planus,” Critical Reviews in Oral Biology and Medicine, vol. 13, no. 4, pp. 350–365, 2002. View at Google Scholar · View at Scopus
  3. D. Eisen, M. Carrozzo, J.-V. B. Sebastian, and K. Thongprasom, “Number V. Oral lichen planus: clinical features and management,” Oral Diseases, vol. 11, no. 6, pp. 338–349, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. M. R. Roopashree, R. V. Gondhalekar, M. C. Shashikanth, J. George, S. H. Thippeswamy, and A. Shukla, “Pathogenesis of oral lichen planus—a review,” Journal of Oral Pathology and Medicine, vol. 39, no. 10, pp. 729–734, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. N. Lavanya, P. Jayanthi, U. Rao, and K. Ranganathan, “Oral lichen planus: an update on pathogenesis and treatment,” Journal of Oral and Maxillofacial Pathology, vol. 15, no. 2, pp. 127–132, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Carrozzo, M. U. de Capei, E. Dametto et al., “Tumor necrosis factor-α and interferon-gamma polymorphisms contribute to susceptibility to oral lichen planus,” Journal of Investigative Dermatology, vol. 122, no. 1, pp. 87–94, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Yamamoto and T. Osaki, “Characteristic cytokines generated by keratinocytes and mononuclear infiltrates in oral lichen planus,” Journal of Investigative Dermatology, vol. 104, no. 5, pp. 784–788, 1995. View at Google Scholar · View at Scopus
  8. W. Iijima, H. Ohtani, T. Nakayama et al., “Infiltrating CD8+ T cells in oral lichen planus predominantly express CCR5 and CXCR3 and carry respective chemokine ligands RANTES/CCL5 and IP-10/CXCL10 in their cytolytic granules: a potential self-recruiting mechanism,” American Journal of Pathology, vol. 163, no. 1, pp. 261–268, 2003. View at Google Scholar · View at Scopus
  9. G. Zhou, K. Xia, G.-F. Du et al., “Activation of nuclear factor-kappa B correlates with tumor necrosis factor-alpha in oral lichen planus: a clinicopathologic study in atrophic-erosive and reticular form,” Journal of Oral Pathology and Medicine, vol. 38, no. 7, pp. 559–564, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Simark-Mattsson, G. Bergenholtz, M. Jontell et al., “Distribution of interleukin-2, -4, -10, tumour necrosis factor-α and transforming growth factor-β mRNAs in oral lichen planus,” Archives of Oral Biology, vol. 44, no. 6, pp. 499–507, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Khan, C. S. Farah, N. W. Savage, L. J. Walsh, D. J. Harbrow, and P. B. Sugerman, “Th1 cytokines in oral lichen planus,” Journal of Oral Pathology and Medicine, vol. 32, no. 2, pp. 77–83, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. X.-A. Tao, C.-Y. Li, N. L. Rhodus, J. Xia, X.-P. Yang, and B. Cheng, “Simultaneous detection of IFN-gamma and IL-4 in lesional tissues and whole unstimulated saliva from patients with oral lichen planus,” Journal of Oral Pathology and Medicine, vol. 37, no. 2, pp. 83–87, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Iwakura and H. Ishigame, “The IL-23/IL-17 axis in inflammation,” Journal of Clinical Investigation, vol. 116, no. 5, pp. 1218–1222, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. B. S. McKenzie, R. A. Kastelein, and D. J. Cua, “Understanding the IL-23-IL-17 immune pathway,” Trends in Immunology, vol. 27, no. 1, pp. 17–23, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. Z. Y. Tan, K. W. Bealgey, Y. Fang, Y. M. Gong, and S. Bao, “Interleukin-23: immunological roles and clinical implications,” International Journal of Biochemistry and Cell Biology, vol. 41, no. 4, pp. 733–735, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Dong, “TH17 cells in development: an updated view of their molecular identity and genetic programming,” Nature Reviews Immunology, vol. 8, no. 5, pp. 337–348, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. M. J. McGeachy, Y. Chen, C. M. Tato et al., “The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo,” Nature Immunology, vol. 10, no. 3, pp. 314–324, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Korn, E. Bettelli, M. Oukka, and V. K. Kuchroo, “IL-17 and Th17 cells,” Annual Review of Immunology, vol. 27, pp. 485–517, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. K. Boniface, B. Blom, Y.-J. Liu, and R. de Waal Malefyt, “From interleukin-23 to T-helper 17 cells: human T-helper cell differentiation revisited,” Immunological Reviews, vol. 226, no. 1, pp. 132–146, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. R. M. Onishi and S. L. Gaffen, “Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease,” Immunology, vol. 129, no. 3, pp. 311–321, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. S. L. Gaffen, “An overview of IL-17 function and signaling,” Cytokine, vol. 43, no. 3, pp. 402–407, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. É. Toussirot, “The IL23/Th17 pathway as a therapeutic target in chronic inflammatory diseases,” Inflammation and Allergy: Drug Targets, vol. 11, no. 2, pp. 159–168, 2012. View at Google Scholar · View at Scopus
  23. P. Hillyer, M. J. Larché, E. P. Bowman et al., “Investigating the role of the interleukin-23/-17A axis in rheumatoid arthritis,” Rheumatology, vol. 48, no. 12, pp. 1581–1589, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. I. Kryczek, A. T. Bruce, J. E. Gudjonsson et al., “Induction of IL-17+ T cell trafficking and development by IFN-γ: mechanism and pathological relevance in psoriasis,” Journal of Immunology, vol. 181, no. 7, pp. 4733–4741, 2008. View at Google Scholar · View at Scopus
  25. J. M. Larsen, C. M. Bonefeld, S. S. Poulsen, C. Geisler, and L. Skov, “IL-23 and TH17-mediated inflammation in human allergic contact dermatitis,” Journal of Allergy and Clinical Immunology, vol. 123, no. 2, pp. 486–e1, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. V. Hölttä, P. Klemetti, T. Sipponen et al., “IL-23/IL-17 immunity as a hallmark of Crohn’s disease,” Inflammatory Bowel Diseases, vol. 14, no. 9, pp. 1175–1184, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Geremia and D. P. Jewell, “The IL-23/IL-17 pathway in inflammatory bowel disease,” Expert Review of Gastroenterology and Hepatology, vol. 6, no. 2, pp. 223–237, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. H. Ohyama, N. Kato-Kogoe, A. Kuhara et al., “The involvement of IL-23 and the Th 17 pathway in periodontitis,” Journal of Dental Research, vol. 88, no. 7, pp. 633–638, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. S. R. Lester, J. L. Bain, R. B. Johnson, and F. G. Serio, “Gingival concentrations of interleukin-23 and -17 at healthy sites and at sites of clinical attachment loss,” Journal of Periodontology, vol. 78, no. 8, pp. 1545–1550, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Wang, Z. Luo, L. Lei et al., “Interaction between oral lichen planus and chronic periodontitis with Th17-associated cytokines in serum,” Inflammation, vol. 36, no. 3, pp. 696–704, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Xie, L. Ding, Z. Xiong, and S. Zhu, “Implications of Th1 and Th17 cells in pathogenesis of oral lichen planus,” Journal of Huazhong University of Science and Technology: Medical Science, vol. 32, no. 3, pp. 451–457, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. E. H. van der Meij, H. Mast, and I. van der Waal, “The possible premalignant character of oral lichen planus and oral lichenoid lesions: a prospective five-year follow-up study of 192 patients,” Oral Oncology, vol. 43, no. 8, pp. 742–748, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Xiong, L. Wei, and B. Peng, “Immunohistochemical localization of IL-17 in induced rat periapical lesions,” Journal of Endodontics, vol. 35, no. 2, pp. 216–220, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. G. Piskin, R. M. R. Sylva-Steenland, J. D. Bos, and M. B. M. Teunissen, “In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin,” Journal of Immunology, vol. 176, no. 3, pp. 1908–1915, 2006. View at Google Scholar · View at Scopus
  35. S. Zhu and Y. Qian, “IL-17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential,” Clinical Science, vol. 122, no. 11, pp. 487–511, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. M.-P. Piccinni, L. Lombardelli, F. Logiodice et al., “Potential pathogenetic role of Th17, Th0, and Th2 cells in erosive and reticular oral lichen planus,” Oral Diseases, vol. 20, no. 2, pp. 212–218, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. Y. Chung and C. Dong, “Don’t leave home without it: the IL-23 visa to TH-17 cells,” Nature Immunology, vol. 10, no. 3, pp. 236–238, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. W. Chi, P. Yang, B. Li et al., “IL-23 promotes CD4+ T cells to produce IL-17 in Vogt-Koyanagi-Harada disease,” Journal of Allergy and Clinical Immunology, vol. 119, no. 5, pp. 1218–1224, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Ichimura, K. Hiratsuka, N. Ogura et al., “Expression profile of chemokines and chemokine receptors in epithelial cell layers of oral lichen planus,” Journal of Oral Pathology and Medicine, vol. 35, no. 3, pp. 167–174, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. Y. Abiko, Y. Jinbu, T. Noguchi et al., “Upregulation of human beta-defensin 2 peptide expression in oral lichen planus, leukoplakia and candidiasis. An immunohistochemical study,” Pathology Research and Practice, vol. 198, no. 8, pp. 537–542, 2002. View at Google Scholar · View at Scopus
  41. M. Nishimura, Y. Abiko, K. Kusano et al., “Localization of human β-defensin 3 mRNA in normal oral epithelium, leukoplakia, and lichen planus: an in situ hybridization study,” Medical Electron Microscopy, vol. 36, no. 2, pp. 94–97, 2003. View at Google Scholar · View at Scopus
  42. C. Dong, “IL-23/IL-17 biology and therapeutic considerations,” Journal of Immunotoxicology, vol. 5, no. 1, pp. 43–46, 2008. View at Publisher · View at Google Scholar · View at Scopus